UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number:000-5463
 
PREMIER BIOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
 
507 River Lakes Parkway
Whitefish, Montana 59937-7803
(312) 718--9393
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
 
Common
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
☐
     
 
 
 
Rule 12g-4(a)(2)
☐
 
 
 
 
Rule 12h-3(b)(1)(i) 
☐
 
 
 
 
Rule 12h-3(b)(1)(ii) 
☐
 
 
 
 
Rule 15d-6 
☒
 
 
 
 
Rule 15d-22(b)
☐
 
 
Approximate number of holders of record as of the certification or notice date: 122.
 
Pursuant to the requirements of the Securities Exchange Act of 1934 [Name of registrant as specified in charter] has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date:
By:
/s/ John Maddox
 
 
John Maddox, President
 
 
 
 

 
Premier Biomedical (PK) (USOTC:BIEI)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Premier Biomedical (PK).
Premier Biomedical (PK) (USOTC:BIEI)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Premier Biomedical (PK).